Stock Alert: CureVac Up 6% After Initiating Phase 2 Trial Of COVID-19 Vaccine
Published
Shares of CureVac N.V. (CVAC) are gaining over 6% on Wednesday morning. Tuesday after the bell, CureVac announced that it has initiated phase 2a clinical trial of its COVID-19 vaccine candidate.
Full Article